Form 4: Medtronic CEO Geoffrey Martha Reports Stock Transactions

Geoffrey Martha, Chairman and CEO of Medtronic, reports the acquisition and disposal of ordinary shares and performance share units on August 2, 2024.

Summary

• On August 2, 2024, Geoffrey Martha, Chairman and CEO of Medtronic, reported transactions involving Medtronic plc ordinary shares and performance share units.
• 18,966 ordinary shares were acquired upon the settlement of performance-vesting restricted stock units at a price of $0.
• 8,649 ordinary shares were disposed of to cover taxes upon the settlement of performance-vesting restricted stock units at a price of $81.51.
• 9,523 ordinary shares were disposed of to cover taxes upon the vesting of restricted stock units at a price of $81.51.
• Following these transactions, Martha directly owns 184,914 ordinary shares.
• Martha also owns 18,966 performance share units.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions, and does not inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
• The transactions are part of the executive compensation plan and may impact employee morale.

Key Dates